MEQRX
Price
$45.82
Change
+$0.07 (+0.15%)
Updated
Jul 25 closing price
Net Assets
2.24B
RWIHX
Price
$72.34
Change
+$0.04 (+0.06%)
Updated
Jul 25 closing price
Net Assets
137.3B
Interact to see
Advertisement

MEQRX vs RWIHX

Header iconMEQRX vs RWIHX Comparison
Open Charts MEQRX vs RWIHXBanner chart's image
MFS Global Equity R2
Price$45.82
Change+$0.07 (+0.15%)
VolumeN/A
Net Assets2.24B
American Funds Capital World Gr&Inc R5E
Price$72.34
Change+$0.04 (+0.06%)
VolumeN/A
Net Assets137.3B
MEQRX vs RWIHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MEQRX vs. RWIHX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEQRX is a Buy and RWIHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIHX has more cash in the bank: 137B vs. MEQRX (2.24B). RWIHX pays higher dividends than MEQRX: RWIHX (1.64) vs MEQRX (0.45). MEQRX was incepted earlier than RWIHX: MEQRX (22 years) vs RWIHX (10 years). MEQRX (1.43) is less costly to investors than RWIHX (0.56). RWIHX is a more actively managed with annual turnover of: 27.00 vs. MEQRX (18.00). MEQRX has a lower initial minimum investment than RWIHX: MEQRX (0) vs RWIHX (250). RWIHX annual gain was more profitable for investors over the last year : 14.00 vs. MEQRX (-0.13). RWIHX return over 5 years is better than : 52.28 vs. MEQRX (4.76).
MEQRXRWIHXMEQRX / RWIHX
Total Expense Ratio1.400.56250%
Annual Report Gross Expense Ratio1.430.56255%
Fund Existence22 years10 years-
Gain YTD10.50715.13469%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.24B137B2%
Annual Yield % from dividends0.451.6428%
Returns for 1 year-0.1314.00-1%
Returns for 3 years-0.0151.75-0%
Returns for 5 years4.7652.289%
Returns for 10 years32.56N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVV41.431.44
+3.60%
Ovintiv
POET6.23-0.01
-0.16%
POET Technologies
AIM8.40-0.02
-0.18%
AIM ImmunoTech Inc
PIII7.27-0.13
-1.76%
P3 Health Partners Inc
CVBF19.27-0.49
-2.48%
CVB Financial Corp